A 4-year Research Study to Demonstrate Value of PET Scans In Alzheimer's Disease Diagnosis

Trial Profile

A 4-year Research Study to Demonstrate Value of PET Scans In Alzheimer's Disease Diagnosis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Jul 2017

At a glance

  • Drugs Florbetaben F18 (Primary) ; Florbetapir F 18 (Primary) ; Flutemetamol-F-18 (Primary)
  • Indications Alzheimer's disease
  • Focus Diagnostic use
  • Acronyms IDEAS
  • Most Recent Events

    • 19 Jul 2017 According to a Piramal Imaging media release, results from the first 3979 participants have been presented at at the 2017 Alzheimer's Association International Conference (AAIC 2017).
    • 19 Jul 2017 Interim results published in the Alzheimer's Association media release.
    • 28 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top